AN2 Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- AN2 Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ANTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001880438
Board of directors
-
Eric Easom · Director · Chief Executive OfficerSince 2023
-
Gilbert Lynn Marks · DirectorSince 2023
-
Joseph S. Zakrzewski · DirectorSince 2023
-
Kabeer Aziz · DirectorSince 2023
-
Margaret M. FitzPatrick · DirectorSince 2023
-
Melvin K. Spigelman · DirectorSince 2023
-
Patricia A. Martin · DirectorSince 2023
-
Robin Shane Readnour · DirectorSince 2023
-
Stephanie Wong · DirectorSince 2023
Chief executives
Eric Easom
· Chief Executive Officer
Dates unknown
Board connections
2 of this board's directors also sit on 2 other boards.
- via Patricia A. Martin
- via Margaret M. FitzPatrick
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $11,602
- 1 purchase by 1 insider
- Sold, last 12 months
- $398,200
- 22 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Trenor Cameron C. III Officer (Chief Medical Officer) | Grant or award | +116,667 | — | — |
| Sep 9, 2026 | Robin Shane Readnour Director | Open-market sale | −523 | $6.02 | $3,151 |
| Sep 9, 2026 | Robin Shane Readnour Director | Open-market sale | −585 | $6.02 | $3,524 |
| Sep 8, 2026 | Robin Shane Readnour Director | Open-market sale | −4,725 | $6.02 | $28,436 |
| Sep 8, 2026 | Robin Shane Readnour Director | Open-market sale | −5,294 | $6.02 | $31,861 |
| Sep 3, 2026 | Robin Shane Readnour Director | Open-market sale | −2,877 | $6.07 | $17,463 |
| Sep 3, 2026 | Robin Shane Readnour Director | Open-market sale | −3,223 | $6.07 | $19,563 |
| Sep 1, 2026 | Margaret M. FitzPatrick Director | Open-market purchase | +2,098 | $5.53 | $11,602 |
| Sep 1, 2026 | Williams Sarah Joanne Officer (Principal Accounting Officer) | Open-market sale | −272 | $5.53 | $1,504 |
| Aug 17, 2026 | Robin Shane Readnour Director | Open-market sale | −16,696 | $6.01 | $100,313 |
| Aug 17, 2026 | Robin Shane Readnour Director | Open-market sale | −18,706 | $6.01 | $112,389 |
| Aug 14, 2026 | Joseph S. Zakrzewski Director | Gift | −405,880 | — | — |
| Jul 10, 2026 | Patricia A. Martin Director | Grant or award | +766 | — | — |
| Jul 10, 2026 | Gilbert Lynn Marks Director | Grant or award | +2,789 | — | — |
| Jul 10, 2026 | Kabeer Aziz Director | Grant or award | +2,852 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.